ANDA 75046, held by Hikma. Butorphanol Tartrate.
As of Nov 16, 2026, ANDA 75046 (Butorphanol Tartrate), held by Hikma, was first approved by FDA on Aug 12, 1998, with 7 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 12, 1998 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Butorphanol Tartrate2MG/ML · injectable;injection | Butorphanol Tartrate | Rx |
| Dec 22, 2025 | Supplement 16Labeling · Standard review | Approved | None posted |
| Jan 10, 2024 | Supplement 15Labeling · Standard review | Approved | None posted |
| Jan 10, 2024 | Supplement 14Labeling · Standard review | Approved | None posted |
| Oct 11, 2019 | Supplement 13Labeling · Standard review | Approved | None posted |
| Oct 30, 2001 | Supplement 3Labeling | Approved | None posted |
| Apr 3, 2001 | Supplement 2Manufacturing | Approved | None posted |
| Oct 15, 1999 | Supplement 1Labeling | Approved | None posted |
| Aug 12, 1998 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters